Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2129 Target Snapshot

Peroxisome proliferator-activated receptor alpha · SINGLE PROTEIN · Rattus norvegicus

107Compounds
33Assays
1Approved Drugs
96.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-15

Protein identity stays anchored to UniProt P37230. Use UniProt P37230 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P37230 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-15
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Peroxisome proliferator-activated receptor alpha as ChEMBL target CHEMBL2129, mapped to UniProt P37230. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Peroxisome proliferator-activated receptor alpha
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-15
ChEMBL target ID
CHEMBL2129
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-15
www.ebi.ac.uk
UniProt accession
P37230
Peroxisome proliferator-activated receptor alpha
UniProt accession via ChEMBL component mapping As of 2026-09-15
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-15
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Peroxisome proliferator-activated receptor alpha is the right protein anchor across sources, using UniProt P37230 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPeroxisome proliferator-activated receptor alpha
UniProt AccessionP37230
Component TypeProtein
Sequence Length468 aa

Peroxisome proliferator-activated receptor alpha

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Peroxisome proliferator-activated receptor alpha, mapped to UniProt P37230. Sequence length is 468 aa.

Mapped IDP37230
Review namePeroxisome proliferator-activated receptor alpha
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

KI17.0
EC5079.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL249865 8.7 EC50 2.0 Preclinical
CHEMBL427710 7.64 EC50 23.0 Preclinical
CHEMBL250036 7.5 EC50 32.0 Preclinical
CHEMBL401315 7.48 EC50 33.0 Preclinical
CHEMBL250041 7.34 EC50 46.0 Preclinical
CHEMBL443585 7.02 EC50 96.0 Preclinical
CHEMBL249868 6.98 EC50 105.0 Preclinical
CHEMBL398684 6.93 EC50 117.0 Preclinical
CHEMBL3828718 6.91 EC50 123.0 Preclinical
CHEMBL398722 6.85 EC50 141.0 Preclinical
Distribution

pChEMBL Value Distribution

8
5.0
12
5.5
7
6.0
23
6.5
3
7.0
2
7.5
0
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

33
Total Assays
51
Tested Compounds
2
Assay Types
Binding — 23 assays, 10 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 16 1 4.8
single protein format 7 9 5.7
Functional — 10 assays, 51 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 6 48 6.4
assay format 4 3 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine